ChestPub Date : 2026-11-01Epub Date: 2026-06-18DOI: 10.1016/j.chest.2026.05.044
Safura-Luise Heidari, Josefine Amalie Loft, Yunus Çolak, Shoaib Afzal, Børge G Nordestgaard, Thomas Benfield, Ken M Kunisaki, Susanne Dam Nielsen, Andreas Ronit
{"title":"Prevalence and Risk Factors of Preserved Ratio Impaired Spirometry in People With HIV and Matched Population Control Participants.","authors":"Safura-Luise Heidari, Josefine Amalie Loft, Yunus Çolak, Shoaib Afzal, Børge G Nordestgaard, Thomas Benfield, Ken M Kunisaki, Susanne Dam Nielsen, Andreas Ronit","doi":"10.1016/j.chest.2026.05.044","DOIUrl":"10.1016/j.chest.2026.05.044","url":null,"abstract":"<p><strong>Background: </strong>People with HIV (PWH) have a higher burden of respiratory comorbidities than the general population, yet emerging spirometry impairments such as preserved ratio impaired spirometry (PRISm) and restrictive spirometry patterns (RSPs) have received limited attention.</p><p><strong>Research question: </strong>Is HIV status associated with PRISm and RSP in well-treated PWH residing in high-income settings?</p><p><strong>Study design and methods: </strong>In a cross-sectional study including 1,080 PWH from the Copenhagen Comorbidity in HIV Infection Study and 12,079 matched population control participants from the Copenhagen General Population Study, we examined the prevalence and explored the association between HIV status and PRISm and RSP. PRISm were defined as FEV<sub>1</sub> to FVC ratio equal to or more than the lower limit of normal (LLN) and FEV<sub>1</sub> less than the LLN, and RSP was defined as FEV<sub>1</sub> to FVC equal to or more than the LLN and FVC less than the LLN. We used multivariable logistic regression analyses and adjusted for HIV-specific and traditional risk factors.</p><p><strong>Results: </strong>The prevalence of PRISm and RSP was higher among PWH compared with population control participants (PRISm: 10.5% [95% CI, 8.8%-12.4%] vs 3.5% [95% CI, 3.2%-3.8%]; P < .01; RSP: 10.6% [95% CI, 8.9%-12.6%] vs 3.2% [95% CI, 2.9%-3.5%]; P < .01). These differences persisted in analyses restricted to people who never smoked. HIV was associated with PRISm and RSP in univariable analyses; in models adjusted for age, sex, smoking status, BMI, and educational level (PRISm: OR, 3.58 [95% CI, 2.77-4.63]; RSP: OR, 4.55 [95% CI, 3.51-5.91]), and in fully adjusted models with alcohol consumption, diabetes, and hypertension (PRISm: OR, 3.40 [95% CI, 2.59-4.47]; RSP: OR, 4.34 [95% CI, 3.29-5.73]). PWH with PRISm or RSP showed a higher burden of respiratory symptoms compared with those without.</p><p><strong>Interpretation: </strong>PWH showed 3-fold higher prevalences of PRISm and RSP compared with population control participants, and HIV was associated independently with these lung function impairments. PRISm and RSP may represent distinct manifestations of HIV-associated lung function impairment.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov; No.: NCT02382822; URL: www.</p><p><strong>Clinicaltrials: </strong>gov.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":"1532-1542"},"PeriodicalIF":9.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148276172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Mediastinal Mass With Recurrent Hemorrhagic Pleural Effusion.","authors":"Zhong-Yin Huang, Zi-Peng He, Xue-Tao Li, Mei-Feng Ye, Zhi-Ke Liang, Yu-Jun Li, Zhu-Xiang Zhao, Shu-Quan Wei","doi":"10.1016/j.chest.2026.04.045","DOIUrl":"https://doi.org/10.1016/j.chest.2026.04.045","url":null,"abstract":"<p><strong>Case presentation: </strong>A 55-year-old man was admitted with a 2-year history of recurrent dyspnea and exertional breathlessness, accompanied by intermittent blood-tinged sputum. During this period, he had been hospitalized 7 times at external institutions, where he underwent extensive investigations including fiberoptic bronchoscopy, endobronchial ultrasound-guided transbronchial needle aspiration, mediastinoscopy, thoracoscopy, and CT imaging-guided biopsy of a mediastinal mass. Empirical antituberculosis therapy also was administered, but no definitive diagnosis was established.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":"170 5","pages":"e165-e170"},"PeriodicalIF":9.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377590","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChestPub Date : 2026-11-01DOI: 10.1016/j.chest.2026.04.055
Tianqiang Sheng, Yiqi Qiu, Gangjian Luo
{"title":"Stratification by Nocturnal BP Dipping Phenotype: A Missing Piece in the FIX PAP Trial.","authors":"Tianqiang Sheng, Yiqi Qiu, Gangjian Luo","doi":"10.1016/j.chest.2026.04.055","DOIUrl":"https://doi.org/10.1016/j.chest.2026.04.055","url":null,"abstract":"","PeriodicalId":9782,"journal":{"name":"Chest","volume":"170 5","pages":"e185-e186"},"PeriodicalIF":9.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377606","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChestPub Date : 2026-11-01Epub Date: 2026-06-11DOI: 10.1016/j.chest.2026.06.003
Larissa Bianchini, Lucas Tramujas, Roger Peron, Alexandre Biasi Cavalcanti, Israel Silva Maia
{"title":"Crossover to Noninvasive Ventilation After High-Flow Nasal Cannula Failure: Insights From the High-Flow Nasal Oxygen Cannula Compared to Non-Invasive Ventilation in Adult Patients with Acute Respiratory Failure Trial.","authors":"Larissa Bianchini, Lucas Tramujas, Roger Peron, Alexandre Biasi Cavalcanti, Israel Silva Maia","doi":"10.1016/j.chest.2026.06.003","DOIUrl":"10.1016/j.chest.2026.06.003","url":null,"abstract":"","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":"1474-1477"},"PeriodicalIF":9.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148223599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChestPub Date : 2026-11-01Epub Date: 2026-06-16DOI: 10.1016/j.chest.2026.06.004
Arash Alavi, Elaine Costa, Monica M S Matsumoto, Nicole Odenwald, Clete Kushida, Amir Bahmani, Robson Capasso
{"title":"Comprehensive Evaluation of Night-to-Night Variability in Polysomnography Metrics and Apnea-Hypopnea Index-Based Diagnostic Reclassification.","authors":"Arash Alavi, Elaine Costa, Monica M S Matsumoto, Nicole Odenwald, Clete Kushida, Amir Bahmani, Robson Capasso","doi":"10.1016/j.chest.2026.06.004","DOIUrl":"10.1016/j.chest.2026.06.004","url":null,"abstract":"<p><strong>Background: </strong>Night-to-night variability (NtNV) in polysomnography findings contributes to diagnostic uncertainty in OSA, yet multimetric evaluations using closely spaced polysomnography nights-particularly in moderate-to-severe disease-remain limited. The comparative stability of apnea-hypopnea index (AHI) definitions, hypoxic burden (HB), and threshold calibration remains unclear.</p><p><strong>Research question: </strong>What is the NtNV across polysomnography-derived metrics, and how do AHI scoring definitions and threshold calibration influence diagnostic stability in OSA?</p><p><strong>Study design and methods: </strong>We performed a retrospective analysis of a prospective study including 147 participants with prior diagnosis or high pretest likelihood of moderate to severe OSA who underwent 2 polysomnography examinations within 10 days. NtNV was quantified across 20 polysomnography-derived metrics. A normalized NtNV matrix was analyzed using principal component analysis (PCA) followed by unsupervised k-means clustering to identify data-driven variability-pattern groups. Diagnostic stability was compared across AHI definitions (3%/arousal vs 4%/arousal) and HB risk categories. Statistical calibration models derived AHI 4% thresholds aligned with AHI 3%/arousal severity cutpoints.</p><p><strong>Results: </strong>NtNV demonstrated heterogeneity. Maximum heart rate (HR), positional fractions, and sleep latency were most variable, whereas average peripheral oxygen saturation (Spo<sub>2</sub>), average HR, minimum Spo<sub>2</sub>, and HB were most stable. In the PCA followed by k-means analysis, respiratory event frequency metrics contributed most strongly and separated participants into lower respiratory variability pattern and higher respiratory variability pattern groups. AHI of 4% showed higher classification disagreement than AHI of 3%/arousal in short-interval (29.9% vs 21.2% overall; 14.3% vs 5.4% at the moderate-to-severe threshold) and longitudinal (45.9% vs 31.1% and 20.9% vs 8.2%, respectively) comparisons. HB showed low internight disagreement (11.8%). Calibration models aligned AHI 4% thresholds of 6.1 to 6.9 events/h and of 18.4 to 22.3 events/h with AHI 3%/arousal cutpoints of 15 and 30 events/h.</p><p><strong>Interpretation: </strong>Our results show that positional, autonomic, and sleep architecture metrics showed the highest NtNV, respiratory event frequency metrics showed intermediate NtNV, and oxygenation showed the most stable NtNV. Greater classification disagreement with AHI 4% was threshold driven, with implications for hypopnea scoring and payer policy in OSA diagnosis.</p><p><strong>Clinical trial registration: </strong>ClinicalTrials.gov; No.: NCT06603441; URL: www.</p><p><strong>Clinicaltrials: </strong>gov.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":"1599-1613"},"PeriodicalIF":9.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148263326","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChestPub Date : 2026-11-01Epub Date: 2026-07-25DOI: 10.1016/j.chest.2026.06.060
Mona Bafadhel, Fernando J Martinez, Gerard J Criner, Donald P Tashkin, Michael E Wechsler, MeiLan K Han, Dave Singh
{"title":"Using Historical Blood Eosinophil Counts to Guide Treatment Decisions in Patients With COPD.","authors":"Mona Bafadhel, Fernando J Martinez, Gerard J Criner, Donald P Tashkin, Michael E Wechsler, MeiLan K Han, Dave Singh","doi":"10.1016/j.chest.2026.06.060","DOIUrl":"10.1016/j.chest.2026.06.060","url":null,"abstract":"<p><p>Up to 40% of patients with COPD have evidence of elevated eosinophil counts ≥ 300 cells/μL at some point during their disease. Blood eosinophil counts (BECs) are a biomarker that can identify patients with COPD and type 2 inflammation who are candidates for add-on inhaled corticosteroids (ICSs) or biologic therapy. Evidence from real-world and clinical trial data shows variation in BECs over time in patients with COPD and type 2 inflammation. This How I Do It article discusses factors that can influence eosinophil counts, reviews how the use of historical eosinophil counts can inform treatment decisions, and provides practical considerations for identifying underlying type 2 inflammation in patients with COPD in the clinic. Currently, there is no consensus on what constitutes \"low\" or \"high\" BEC in COPD or the frequency or number of eosinophil measurements needed to effectively guide disease management. Based on our experience from the clinic and available literature, we propose 4 broad phenotypic groups of patients with COPD: those with BECs predominantly ≥ 300 cells/μL, intermittently ≥ 300 cells/μL, within an intermediate range of 100 to 300 cells/μL, and those with BECs predominantly < 100 cells/μL. Identifying these patterns can help with more precise stratification for pharmacologic interventions, such as adding ICSs or biologic therapies. Although single BEC measurements are easy to obtain and often sufficient to identify patients with COPD and high levels of type 2 inflammation, when interpreted alongside clinical characteristics, repeated BECs may be able to support a more personalized approach to COPD care.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":" ","pages":"1438-1447"},"PeriodicalIF":9.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148590721","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChestPub Date : 2026-11-01DOI: 10.1016/j.chest.2026.05.008
Jacob Reep, Cesar Trillo-Alvarez, Zahraa Ghandour, Cynthia Gries, Moustafa Younis, Brandon Janssen, Adriana Valverde Zúñiga, Mohammad Aladaileh, Mindaugas Rackauskas, Amir Emtiazjoo
{"title":"Bilateral Pulmonary Nodules After Lung Transplantation: A Rare Diagnosis.","authors":"Jacob Reep, Cesar Trillo-Alvarez, Zahraa Ghandour, Cynthia Gries, Moustafa Younis, Brandon Janssen, Adriana Valverde Zúñiga, Mohammad Aladaileh, Mindaugas Rackauskas, Amir Emtiazjoo","doi":"10.1016/j.chest.2026.05.008","DOIUrl":"https://doi.org/10.1016/j.chest.2026.05.008","url":null,"abstract":"<p><strong>Case presentation: </strong>A 64-year-old man who underwent bilateral orthotopic lung transplant for emphysema related to α1-antitrypsin deficiency 8 months ago presented to the clinic for assessment of bilateral pulmonary nodules identified on routine postlung transplant surveillance without any symptomatic concerns. The donor was positive for cytomegalovirus and positive for Epstein-Barr virus, and the recipient was negative for cytomegalovirus and positive for Epstein-Barr virus. He denied any fever, chills, cough, chest pain, dyspnea, weight loss, or night sweats. The patient lived in South Florida with no recent travel history outside the United States or infectious contacts. His posttransplant course was complicated with antibody-mediated rejection at 1.5 months after lung transplant. Antibody-mediated rejection was successfully treated with our institutional multimodal regimen, including a combination of plasmapheresis, carfilzomib, and anti-thymocyte globulin followed by monthly IV immunoglobulin and tocilizumab injections. Also, because of calcineurin inhibitor (CNI)-related renal dysfunction, the patient's immunosuppression was converted to a belatacept-based CNI-sparing regimen in addition to prednisone, with a tacrolimus goal trough of 4 to 6 ng/mL. He was also placed on mycophenolic acid, which was soon held because of neutropenia.</p>","PeriodicalId":9782,"journal":{"name":"Chest","volume":"170 5","pages":"e149-e153"},"PeriodicalIF":9.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377582","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChestPub Date : 2026-11-01DOI: 10.1016/j.chest.2026.07.5211
Hari M Shankar
{"title":"Counting What We Waste: The Environmental Burden of Bronchoscopy.","authors":"Hari M Shankar","doi":"10.1016/j.chest.2026.07.5211","DOIUrl":"https://doi.org/10.1016/j.chest.2026.07.5211","url":null,"abstract":"","PeriodicalId":9782,"journal":{"name":"Chest","volume":"170 5","pages":"1354-1355"},"PeriodicalIF":9.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
ChestPub Date : 2026-11-01DOI: 10.1016/j.chest.2026.06.038
Wallace B Wee, Adam J Shapiro
{"title":"References Early Detection of Structural Lung Damage in Primary Ciliary Dyskinesia.","authors":"Wallace B Wee, Adam J Shapiro","doi":"10.1016/j.chest.2026.06.038","DOIUrl":"https://doi.org/10.1016/j.chest.2026.06.038","url":null,"abstract":"","PeriodicalId":9782,"journal":{"name":"Chest","volume":"170 5","pages":"1349-1350"},"PeriodicalIF":9.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377596","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}